BLRX · BioLineRx Ltd.

NasdaqHealthcareBiotechnology

Bioline Rx Ltd Is A Commercial-Stage Biopharmaceutical Company Focused On Oncology. The Company'S Current Development And Commercialization Pipeline Consists Of Two Clinical-Stage Therapeutic Candidates Motixafortide (Bl-8040), A Novel Peptide For The Treatment Of Stem-Cell Mobilization And Solid Tumors, And Agi-134, An Immuno-Oncology Agent In Development For Solid Tumors. In Addition, The Company Has A Legacy Therapeutic Product Called Bl-5010 For The Treatment Of Skin Lesions. The Company Has Generated Revenues From Milestone Payments Under Previously Existing Out-Licensing Agreements.

HealthcareNasdaqILVery Low Float

FLOAT

4.1M

FREE FLOAT %

83%

SHARES O/S

5.0M

MARKET CAP

$10.2M

EXCHANGE

Nasdaq

COUNTRY

BLRX Catalyst History

No catalysts recorded for BLRX yet

Day Trader Sniper hasn't classified a publishable catalyst for BLRX yet. New events appear here as they're scored.

Be early on the next BLRX spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

BLRX · BioLineRx Ltd.

BLRX Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.